GrëtelCannon

Associate

Melbourne + 61.3.9101.6863

Connect:

Share

Grëtel Cannon's practice focuses on high-value, complex construction and engineering disputes, with an emphasis on international arbitration and cross-border dispute resolution.

Prior to joining Jones Day's Melbourne Office, Grëtel worked in Jones Day's Singapore Office. Grëtel's experience includes several major international arbitrations under ICC (International Chamber of Commerce), SIAC (Singapore International Arbitration Centre), HKIAC (Hong Kong International Arbitration Centre), and DIFC-LCIA (Dubai International Arbitration Centre–London Court of International Arbitration) Rules of Arbitration, including representing a construction joint venture in a multimillion dollar dispute with its consortium member regarding a power plant project in the Middle East. Through this matter, Grëtel gained in-depth experience in large-scale virtual hearings.

Grëtel has also assisted: in a multibillion dollar arbitration in relation to a gas pipeline in the Middle East, in proceedings challenging an arbitral award in Singapore and Australia, and local counsel in advising a defrauded technology company in civil proceedings.

Grëtel's recent experience includes acting for a joint venture for a mining project in NSW Supreme Court litigation as well as advising an overseas contractor in relation to disputes arising from a solar farm project in Australia. She also has been seconded to the Melbourne headquarters of an international engineering and construction company where she assisted with procurement and construction negotiations in the infrastructure sector and advised on various compliance issues.

Experience

  • Major pharmaceutical company arbitrates claims arising out of Chinese investmentsJones Day is representing a major pharmaceutical company in a Hong Kong International Arbitration Centre arbitration arising out of representations and warranties given in respect of the client's investment in a Chinese drug development company whose senior officers and consultants were subsequently prosecuted in the United States for misappropriation of another pharmaceutical company's trade secrets.
  • U.S. technology company obtains two judgments in excess of US$1.5 million against co-conspirators to fraudulent schemeJones Day advised a U.S. technology company, with the assistance of local counsel in several jurisdictions, in relation to a cross-border litigation regarding a fraudulent scheme involving a former employee and a subcontractor.
  • Major U.S. contractor and technology licensor resolves dispute against Indian licenseeJones Day represented a major U.S. contractor and technology licensor against an Indian licensee in a SIAC-seated arbitration arising out of a long-term technology collaboration agreement.
    • View All

    April 2022 Commentary

    DIAC 2022 Arbitration Rules: Will They Propel DIAC Into a Top-Five Institution?

    October 2021 Commentary

    Australia Introduces the Offshore Electricity Infrastructure Bill 2021

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.